Mechanistic studies of the Nrf2-Keap1 signaling pathway

Drug Metabolism Reviews

Volumn 38, Issue 4, 2006, Pages 769-789

  Zhang, Donna D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Chemopreventive compounds; Degradation; Keap1; Nrf2; Oxidative stress; Ubiquitin ligase; Ubiquitination

Indexed keywords

CULLIN; CYTOPLASM PROTEIN; REPRESSOR PROTEIN; SULFORAPHANE; TERT BUTYLHYDROQUINONE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR KEAP1; TRANSCRIPTION FACTOR NRF2; UBIQUITIN PROTEIN LIGASE E3;

ANTIOXIDANT RESPONSIVE ELEMENT; AUTOIMMUNE DISEASE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DEFENSE MECHANISM; ELECTROPHILIC STRESS; ENZYME INHIBITION; EUKARYOTIC CELL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; INFLAMMATION; LUNG INJURY; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 33845442925     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602530600971974     Document Type: Conference Paper

References (73)

1. Aoki, Y., Sato, H., Nishimura, N., Takahashi, S., Itoh, K., Yamamoto, M. (2001). Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol. Appl. Pharmacol. 173:154-160.
2. Braun, S., Hanselmann, C., Gassmann, M. G., auf dem Keller, U., Born-Berclaz, C., Chan, K., Kan, Y. W., Werner, S. (2002). Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol. Cell. Biol. 22:5492-5505.
3. Chan, J. Y., Kwong, M., Lu, R., Chang, J., Wang, B., Yen, T. S., Kan, Y. W. (1998). Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. Embo. J. 17:1779-1787.
4. Chan, K., Han, X. D., Kan, Y. W. (2001). An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc. Natl. Acad. Sci. USA 98:4611-4616.
5. Chan, K., Lu, R., Chang, J. C., Kan, Y. W. (1996). NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. USA 93:13943-13948.
6. Chanas, S. A., Jiang, Q., McMahon, M., McWalter, G. K., McLellan, L. I., Elcombe, C. R., Henderson, C. J., Wolf, C. R., Moffat, G. J., Itoh, K., Yamamoto, M., Hayes, J. D. (2002). Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 365:405-416.
7. Cho, H. Y., Jedlicka, A. E., Reddy, S. P., Kensler, T. W., Yamamoto, M., Zhang, L. Y., Kleeberger, S. R. (2002). Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell. Mol. Biol. 26:175-182.
8. Cho, H. Y., Reddy, S. P., Debiase, A., Yamamoto, M., Kleeberger, S. R. (2005). Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med. 38:325-343.
9. Cho, H. Y., Reddy, S. P., Yamamoto, M., Kleeberger, S. R. (2004). The transcription factor NRF2 protects against pulmonary fibrosis. Faseb. J. 18:1258-1260.
10. Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., Diehl, J. A. (2004). The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 24:8477-8486.
11. Delaunay, A., Pflieger, D., Barrault, M. B., Vinh, J., Toledano, M. B. (2002). A thiol peroxidase is an H2O2 receptor and redox-transducer in gene activation. Cell 111:471-481.
12. Derjuga, A. Gourley, T. S., Holm, T. M., Heng, H. H., Shivdasani, R. A., Ahmed, R., Andrews, N. C., Blank, V. (2004). Complexity of CNC transcription factors as revealed by gene targeting of the Nrf3 locus. Mol. Cell. Biol. 24:3286-3294.
13. Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., Talalay, P. (2002). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99:11908-11913.
14. Dinkova-Kostova, A. T., Massiah, M. A., Bozak, R. E., Hicks, R. J., Talalay, P. (2001). Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc. Natl. Acad. Sci. USA 98:3404-3409.
15. Eggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., Mesecar, A. D. (2005). Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. Proc. Natl. Acad. Sci. USA 102:10070-10075.
16. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T., Yamamoto, M. (2001). High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59:169-177.
17. Furukawa, M., Xiong, Y. (2005). BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 25:162-171.
18. Gao, X., Talalay, P. (2004). Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc. Natl. Acad. Sci. USA 101:10446-10451.
19. Hochstrasser, M. (1996). Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30:405-439.
20. Hong, F., Sekhar, K. R., Freeman, M. L., Liebler, D. C. (2005). Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J. Biol. Chem. 280:31768-31775.
21. Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., Yamamoto, M. (2004). Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64:6424-6431.
22. Ishii, Y., Itoh, K., Morishima, Y., Kimura, T., Kiwamoto, T., Iizuka, T., Hegab, A. E., Hosoya, T., Nomura, A., Sakamoto, T., Yamamoto, M., Sekizawa, K. (2005). Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J. Immunol. 175:6968-6975.
23. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76-86.
24. Jain, A. K., Bloom, D. A., Jaiswal, A. K. (2005). Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280:29158-29168.
25. Jain, A. K., Jaiswal, A. K. (2006). Phosphorylation of tyrosine 568 controls nuclear export of Nrf2. J. Biol. Chem. 281:12132-12142.
26. Jeyapaul, J., Jaiswal, A. K. (2000). Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem. Pharmacol. 59:1433-1439.
27. Kamura, T., Koepp, D. M., Conrad, M. N., Skowyra, D., Moreland, R. J., Iliopoulos, O., Lane, W. S., Kaelin, W. G., Jr., Elledge, S. J., Conaway, R. C., Harper, J. W., Conaway, J. W. (1999). Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science 284:657-661.
28. Karapetian, R. N., Evstafieva, A. G., Abaeva, I. S., Chichkova, N. V., Filonov, G. S., Rubtsov, Y. P., Sukhacheva, E. A., Melnikov, S. V., Schneider, U., Wanker, E. E., Vartapetian, A. B. (2005). Nuclear oncoprotein prothymosin alpha is a partner of Keap1: implications for expression of oxidative stress-protecting genes. Mol. Cell. Biol. 25:1089-1099.
29. Katoh, Y., Itoh, K., Yoshida, E., Miyagishi, M., Fukamizu, A., Yamamoto, M. (2001). Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 6:857-868.
30. Kensler, T. W., Curphey, T. J., Maxiutenko, Y., Roebuck, B. D. (2000). Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol. Drug Interact. 17:3-22.
31. Kleiner, H. E., Rivera, M. I., Pumford, N. R., Monks, T. J., Lau, S. S. (1998). Immunochemical detection of quinol - thioether-derived protein adducts. Chem. Res. Toxicol. 11:1283-1290.
32. Kobayashi, A., Kang, M. I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24:7130-7139.
33. Kobayashi, A., Kang, M. I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., Yamamoto, M. (2006). Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26:221-229.
34. Kwak, M. K., Itoh, K., Yamamoto, M., Sutter, T. R., Kensler, T. W. (2001). Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3-thione. Mol. Med. 7:135-145.
35. Kwak, M. K., Wakabayashi, N., Itoh, K., Motohashi, H., Yamamoto, M., Kensler, T. W. (2003). Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278:8135-8145.
36. Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W., Johnson, J. A. (2003). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278:12029-12038.
37. Levonen, A. L., Landar, A., Ramachandran, A., Ceaser, E. K., Dickinson, D. A., Zanoni, G., Morrow, J. D., Darley-Usmar, V. M. (2004). Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem. J .378:373-382.
38. Li, W., Jain, M. R., Chen, C., Yue, X., Hebbar, V., Zhou, R., Kong, A. N. (2005). Nrf2 Possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem. 280:28430-28438.
39. Li, X., Zhang, D. D., Hannink, M., Beamer, L. J. (2004). Crystal structure of the Kelch domain of human Keap1. J. Biol. Chem. 279:54750-54758.
40. Lo, S. C., Hannink, M. (2006). CAND1-mediated substrate adaptor recycling is required for efficient repression of Nrf2 by Keap1. Mol. Cell. Biol. 26:1235-1244.
41. Moi, P., Chan, K., Asunis, I., Cao, A., Kan, Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. USA 91:9926-9930.
42. Nguyen, T., Huang, H. C., Pickett, C. B. (2000). Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275: 15466-15473.
43. Nguyen, T., Sherratt, P. J., Nioi, P., Yang, C. S., Pickett, C. B. (2005). Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J. Biol. Chem. 280:32485-32492.
44. Nioi, P., McMahon, M., Itoh, K., Yamamoto, M., Hayes, J. D. (2003). Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 374:337-348.
45. Nioi, P., Nguyen, T., Sherratt, P. J., Pickett, C. B. (2005). The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol. Cell. Biol. 25:10895-10906.
46. Orsolic, N., Sver, L., Terzic, S., Basic, I. (2005). Peroral application of water-soluble derivative of propolis (WSDP) and its related polyphenolic compounds and their influence on immunological and antitumour activity. Vet. Res. Commun. 29:575-593.
47. Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M. I., Kobayashi, A., Yokoyama, S., Yamamoto, M. (2006). Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol. Cell 21:689-700.
48. Pickart, C. M. (2001). Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70:503-533.
49. Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., Kensler T. W. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc. Natl. Acad. Sci. USA 98:3410-3415.
50. Rangasamy, T., Cho, C. Y., Thimmulappa, R. K., Zhen, L., Srisuma, S. S., Kensler, T. W., Yamamoto, M., Petrache, I., Tuder, R. M., Biswal, S. (2004). Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 114:1248-1259.
51. Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N., Biswal, S. (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J. Exp. Med. 202:47-59.
52. Richardson, H. L., Cunningham, L. (1951). The inhibitory action of methylcholanthrene on rats fed the azo dye 3′-methyl-4- dimethylaminobenzene. Cancer Res. 11:274.
53. Salazar, M., Rojo, A. I., Velasco, D., de Sagarra, R. M., Cuadrado, A. (2006). Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor nrf2. J. Biol. Chem. 281:14841-14851.
54. Shen, G., Xu, C., Hu, R., Jain, M. R., Nair, S., Lin, W., Yang, C. S., Chan, J. Y., Kong, A. N. (2005). Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Pharm. Res. 22:1805-1820.
55. Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., Murphy, T.H. (2005a). Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280:22925-22936.
56. Shih, A. Y., Li, P., Murphy, T. H. (2005b). A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J. Neurosci. 25:10321-10335.
57. Shivdasani, R. A., Rosenblatt, M. F., Zucker-Franklin, D., Jackson, C. W., Hunt, P., Saris, C. J., Orkin, S. H. (1995). Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695-704.
58. Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R. M., Hagen, T. M. (2004). Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proc. Natl. Acad. Sci. USA 101:3381-3386.
59. Talalay, P., Fahey, J. W. (2001.) Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J. Nutr. 131:3027S-3033S.
60. Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., Biswal, S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196-5203.
61. Velichkova, M., Hasson, T. (2005). Keap1 regulates the oxidation-sensitive shuttling of Nrf2 into and out of the nucleus via a Crm1-dependent nuclear export mechanism. Mol. Cell. Biol. 25:4501-4513.
62. Venugopal, R., Jaiswal, A. K. (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93:14960-14965.
63. Wakabayashi, N., Dinkova-Kostova, A. T., Holtzclaw, W. D., Kang, M. I., Kobayashi, A., Yamamoto, M., Kensler, T. W., Talalay, P. (2004). Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. USA 101:2040-2045.
64. Wei, N., Deng, X. W. (2003). The COP9 signalosome. Annu. Rev. Cell. Dev. Biol .19:261-286.
65. Wild, A. C., Moinova, H. R., Mulcahy, R. T. (1999). Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J. Biol. Chem. 274:33627-33636.
66. Wolf, C. R. (2001). Chemoprevention: increased potential to bear fruit. Proc. Natl. Acad. Sci. USA 98:2941-2943.
67. Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., Ben-Neriah, Y. (1998). Identification of the receptor component of the Ikappa-Balpha-ubiquitin ligase. Nature 396:590-594.
68. Yoh, K., Itoh, K., Enomoto, A., Hirayama, A., Yamaguchi, N., Kobayashi, M., Morito, N., Koyama, A., Yamamoto, M., Takahashi, S. (2001). Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int. 60:1343-1353.
69. Zhang, D. D., Hannink, M. (2003). Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol. Cell. Biol. 23:8137-8151.
70. Zhang, D. D., Lo, S. C., Cross, J. V., Templeton, D. J., Hannink, M. (2004). Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24:10941-10953.
71. Zhang, Y., Kensler, T. W., Cho, C. G., Posner, G. H., Talalay, P. (1994). Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc. Natl. Acad. Sci. USA 91:3147-3150.
72. Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., Conaway, R. C., Conaway, J. W., Harper, J. W., Pavletich, N. P. (2002). Structure of the Cul1-Rbx1-Skp1-F-boxSkp2 SCF ubiquitin ligase complex. Nature 416:703-709.
73. Zipper, L. M., Mulcahy, R. T. (2002). The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm. J. Biol. Chem. 277:36544-36552.